Brexit: A bumpy road but we favor a benign outcome

The Brexit drama is in full swing. Just 36 days before the UK is scheduled to leave the EU on March 29, the uncertainty and conflicts surrounding the fate of the Brexit deal are still substantial.

Highlights:

  • Only 36 days before the scheduled Brexit date on March 29, 2019 UK PM Theresa May’s Brexit deal with the EU still lacks parliamentary approval. Overall, the current situation is very fluid.
  • PM May is trying to win over the hard Brexiteers within her own party by demanding additional concessions from the EU. While the EU avoids renegotiating the withdrawal agreement, a legally binding addendum remains an option.
  • PM May intends to further run down the clock, in order to present her deal as the only possible alternative to a crash Brexit. But Parliament is likely to stop that process on Feb. 27, by forcing an extension request for the Brexit deadline.
  • Alternative options (e.g. second referendum, new elections or the withdrawal from Article 50) are hardly attractive.
  • In sum, we still see a benign outcome of the Brexit showdown still more likely than not, as hard Brexiteers throw the towel in on the fear of a Brexit unwind and/or rebel labour MPs help the deal pass. As in any chicken game an accident cannot be excluded, but our underlying views create a positive bias towards GBP and domestic UK stocks.

Read the full publication below.

BREXIT: A BUMPY ROAD
BUT WE FAVOR A
BENIGN OUTCOME

RELATED INSIGHTS

COVID-19 FACTS & FIGURES
According to the IMF’s Managing Director, strong international cooperation on coronavirus vaccine could speed up the world economic recovery and add $9 trillion to global income by 2025. A WHO trial found that Remdesivir, Hydroxychloroquine, Lopinavir and Interferon have little or no effect on hospitalized Covid-19 patients. Gilead Sciences has questioned the findings of the WHO study saying data appeared inconsistent.
INCORPORATING QUANT SIGNALS INTO EU EQUITY SECTOR/STYLE STRATEGY: MAINTAIN A TILT TO CYCLICALS AND VALUE
We present an update of our proprietary equity valuation tool, based on quant models. It provides indications of over- or undervaluation for different sectors and styles of European equities, which is further enriched by our qualitative analysis. Currently, among European equity sectors, financials, energy, telecoms, and autos look undervalued while Pharma, utilities and software appear overvalued.
CHINA’S RECOVERY CONTINUED BUT A BIT SOFTER THAN EXPECTED
China's economic recovery continued in Q3 2020, although a bit softer than expected. Real GDP growth rose to 4.9% yoy, slightly below the Reuters consensus expectation of 5.2% yoy, but still a substantial upturn from the 3.2% yoy in Q2. On a quarterly base, growth dynamics softened to 2.7% qoq, after 11.7% qoq and -10% qoq in the two previous quarters.